HIGHLIGHTS
- who: Leqiang Zhang from the Sichuan University, China have published the article: Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy, in the Journal: (JOURNAL)
- what: The main reason is that the relevant mechanisms of lipid metabolism are not fully revealed in hematological malignancies.
SUMMARY
Hematological malignancies are a collection of malignant tumors that aberrant hematological cells or immune cells are blocked in differentiation and proliferate indefinitely, leading to the dysfunction of biological organisms. In this review, the authors discuss the lipid metabolism reprogramming and its oncogenic mechanisms in hematological . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.